Decision counseling after a Shield+ colorectal cancer screening result
Part of Cancer, Digestive system clinical trials.
This study offers a counseling session to help people who have a positive Shield blood test result for colorectal cancer understand their options and next steps. The goal is to support you in making informed decisions about follow-up care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 45 and 75 years old
- You had a Shield blood test that came back positive
- You are willing to talk about your results in English
- You have not already been enrolled in another Guardant Health study
- Your positive result is not for a cancer type other than colorectal cancer
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing the Shield blood test for people at average risk of colorectal cancer. It looks at how well the test works for screening, so you can learn about your risk with a simple blood draw.
This trial helps people aged 40-49 who have a parent, sibling, or child with colorectal cancer decide on the best way to get screened. It aims to find the most effective screening method for those at higher risk.
This trial is testing a simple program to help people who are due for colorectal cancer screening to complete their test. It's for patients at Cornell Scott Hill Health who either haven't finished a screening order or had an abnormal stool test without follow-up.
This study tests a program to help people learn about colorectal cancer screening. If you are 45 to 75 and due for screening, you may be able to join.
This trial is testing a blood test called Guardant Shield to see if it can effectively screen for colorectal cancer (a common cancer of the colon or rectum). If you're between 45 and 85 and overdue for a screening, this test could be a simpler alternative to colonoscopy or stool tests.
This study tests whether training doctors to better involve patients in decisions about colorectal cancer screening improves shared decision-making. If you are between 50 and 74 and due for screening, your GP might invite you to join.
Hear when a new Colo-rectal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.